Healius Ltd

Healius has a debt-to-equity ratio of 1.55, indicating a significant reliance on debt financing, and a current ratio of 0.56, suggesting potential liquidity constraints. The company's operating cash flow is positive at 285.7 million AUD, but its free cash flow is negative at -691.4 million AUD, reflecting high capital expenditures and operational costs. The company's profitability is underperforming, with a return on equity of -25.72% and a return on assets of -8.51%, both significantly below the industry median for healthcare facilities and services. This indicates that Healius is not generating returns that meet the expectations of its equity and asset base. Healius operates through multiple brands across various regions in Australia, including Queensland, New South Wales, and Victoria. However, the company's revenue concentration is not disclosed, and there is no information on the relative contribution of each segment to the overall revenue. The company's revenue is expected to remain flat in the current fiscal year, with no significant growth anticipated in the next fiscal year. This is supported by the company's negative net income of -151.2 million AUD and an operating loss of -527 million AUD, which suggests operational inefficiencies or cost overruns. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's net cash is negative after subtracting total debt, which could impact its ability to meet short-term obligations. The dilution risk is low, but the company's capital structure and financial performance suggest a need for careful monitoring of its debt levels and cash flow management. Recent events include the company's financial performance, which has been marked by a significant operating loss and negative net income. The company's capital expenditures have also been high, with a capital expenditure of -65.9 million AUD, which may indicate ongoing investments in infrastructure or expansion.